A Study to Evaluate Safety and Efficacy of Subcutaneous Administration of Anakinra in Patients With CF
NCT03925194
·
clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
52
Enrollment
OTHER
Sponsor class
Conditions
Cystic Fibrosis, 10011762
Interventions
DRUG:
Anakinra
Sponsor
Heidelberg University